• Zum Inhalt springen
  • Zur Navigation springen
  • Zum Seitenende springen
Organisationsmenü öffnen Organisationsmenü schließen
Logo of the
  • FAUZur zentralen FAU Website
  1. Friedrich-Alexander-Universität
  2. Technische Fakultät
  • Mein Campus
  • UnivIS
  • Stellenangebote
  • Lageplan
  • Hilfe im Notfall
  1. Friedrich-Alexander-Universität
  2. Technische Fakultät

Logo of the

Menu Menu schließen
  • About Us
    • Staff
    • Open Positions
    • Graduation
    • Our Labs
    • Contact
    Portal About Us
  • Research
    • Research Groups
    • Collaborations
    • Publications
    Portal Research
  • Teaching
    • Lectures
    • Scientific Talks
    Portal Teaching
  1. Startseite
  2. Research
  3. Research Groups
  4. Malaria Biotechnology
  5. Malaria vaccine directed against blood stages

Malaria vaccine directed against blood stages

Bereichsnavigation: Research
  • Research Groups
    • Muscle Opto-Biomechatronics
      • The MyoRobot
      • Tissue Regenerator
      • The MechaMorph
      • The IsoStretcher
      • Virtual Laboratory
    • Malaria Biotechnology
      • RG Protein Engineering
      • Metabolic enzymes as drug targets
      • Identification of novel antimalarial compounds
      • Mitosis as drug target
      • Identification of transporters of the MGC-basic proteins
      • Characterization of drug-resistance transporters of the digestive vacuole
      • Malaria vaccine directed against blood stages
    • Tissue Engineering
      • Research Topic 1 (TE)
      • Research Topic 2 (TE)
      • Research Topic 3 (TE)
    • Optical Technologies in Life Sciences
      • Label-free Multiphoton Imaging
      • Multiphoton Endomicroscopy for Life Science and Medicine
      • Raman Spectroscopy of Biological Tissue
      • PiezoGRIN: Multiphoton Imaging under high Pressures
    • High-throughput Biology & Robophotonics
      • High-throughput Biology & Functional Neurogenomics
      • Robophotonics & Rapid Prototyping
  • Collaborations
  • Publications

Malaria vaccine directed against blood stages

Group Leader

Nina Simon

Dr. Nina Simon

Group Leader

Medical Biotechnology
Malaria Biotechnology

Raum: Raum 00.115
Ulrich-Schalk-Str. 3
91056 Erlangen
Germany
  • Telefon: +49 9131 85-69657
  • E-Mail: nina.simon@fau.de

Various pathogens are known to escape human complement recognition by recruiting complement regulating proteins to provide protection against the host’s immune system. This immune evasion mechanism was reported for asexual malaria blood stages. The blockage of a complement protein receptor in merozoites should result in increased complement destruction and thereby, may inhibit the completion of the intra-erythrocytic replication cycle of the malaria parasite within its human host. It is, therefore, conceivable to evaluate the efficacy of new malaria-vaccines directed against complement protein-receptor proteins. One example (shown in the picture) would be the blockage of the receptor which binds the human complement regulation factor H protein on its surface (Simon et al., 2018).

Friedrich-Alexander-Universität
Erlangen-Nürnberg

Schlossplatz 4
91054 Erlangen
  • Imprint
  • Privacy
  • Accessibility
Nach oben